Stellar Solutions works with hospitals, surgery centers, and physician practices to significantly reduce what they spend on biologics, implants, and orthopedic supplies — while simultaneously unlocking compliant clinical revenue. We combine manufacturer relationships, smarter contracting, and clinical utilization expertise to reduce total supply costs — sometimes through better pricing, sometimes through eliminating overuse, often both.
We combine smarter sourcing, clinical standardization, and compliant revenue growth to deliver results that don't require new workflows or upfront investment.
We reduce what health systems actually spend on biologics, orthopedics, spine, joint replacement, and trauma — through a combination of sourcing strategy, contract optimization, and clinical utilization review. Sometimes the savings come from better pricing. Often they come from eliminating overuse and standardizing how much product is actually needed to achieve the same or better clinical outcome.
Purchase price is one lever. The deeper, more durable savings come from looking at total cost of care — including the soft costs that rarely make it onto a supply chain report. We help systems reduce tray counts and sterilization burden, identify products that reduce revision rates and readmissions, and standardize protocols that shorten patient length of stay and reduce post-operative pain. We also identify products carrying New Technology Add-On Payments (NTAPs) — where CMS provides incremental reimbursement for newer technologies — turning a supply decision into a net revenue opportunity rather than just a cost.
An AI-driven platform paired with licensed clinicians reviews patient charts to surface additional billable services under collaborative care models — often multiple times per patient, per year. We also identify product-level reimbursement opportunities: where NTAP-eligible technologies or better-reimbursed alternatives can shift a cost center into a margin driver. No EHR integration, no new workflows, no upfront cost.
From independent practices to large integrated health systems — if you purchase supplies and bill for services, we can improve your margins.
System-wide supply chain reviews consistently identify seven-figure annual savings in high-utilization biologic and implant categories.
ASCs seeking to reduce implant and biologic costs while maintaining surgeon autonomy and clinical quality standards.
Independent and group practices looking to increase per-patient revenue compliantly — without adding administrative burden.
"The biggest savings we find aren't always in the price. They're in the usage. Most systems are spending more product per case than the outcome requires — and nobody's told them."
— Stellar Solutions
We sit at the intersection of clinical insight, supply chain strategy, and AI-driven revenue identification. In some categories, we improve pricing through direct manufacturer relationships and smarter contracting. In others — often more impactful — the savings come from clinical utilization work: identifying where product is being overused and standardizing around what the outcome actually requires. When more product is being used than the outcome requires — or multiple products combined where one would suffice — that's not a pricing problem. It's a data and standardization problem. Most cost reduction programs never look this deep. We do. Most GPO relationships only touch price. We go deeper.
We'll do a confidential review of your supply spend and billing profile — and show you specifically where savings and revenue opportunities exist before you commit to anything.
Request a ConsultationOr email us directly: brock@stellarsolutions.llc